Home
Conditions
Lung Diseases, Obstructive

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

8,006 public trials 745 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy

NCT04184297

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: HealthCore, Inc. Andover, Massachusetts, United States

View Trial Details

Completed

Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects

NCT04229303

Conditions: Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Aspergillosis, Allergic Bronchopulmonary, +15 more
Locations: Medicines Evaluation Unit Ltd. (MEU) Manchester, United Kingdom

View Trial Details

Completed

A Pilot Study to Assess Treatment of Patients With Homogeneous Emphysema Using Sequential Segmental Bronchoscopic Thermal Vapor Ablation (NEXT STEP)

NCT03670121

Conditions: Chronic Disease, Disease Attributes, Emphysema, +7 more
Locations: Thoraxklinik University of Heidelberg Heidelberg, Germany

View Trial Details

Completed

Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study

NCT04926233

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: AETION inc New York, United States

View Trial Details

Completed

Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS

NCT04138758

Conditions: COPD, Chronic Disease, Disease Attributes, +6 more
Locations: HealthCore, Inc. Watertown, Massachusetts, United States

View Trial Details

Completed

A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT03979807

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Aetion Inc. New York, United States

View Trial Details

Completed

Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma

NCT00232999

Conditions: Asthma, Bronchial Diseases, Bronchial Hyperreactivity, +7 more
Locations: Department of Medicine, McMaster University Hamilton, Ontario, Canada

Centre de cardiology et de pneumologie de l'Universite Laval Sainte-Foy (Quebec City), Quebec, Canada

University of Saskatchewan Saskatoon, Saskatchewan, Canada

View Trial Details

Completed

Albuterol HFA MDI in Pediatric Participants With Asthma

NCT00577655

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Pediatric Care Medical Group, Inc. Huntington Beach, California, United States

California Allergy & Asthma Medical Group Palmdale, California, United States

Center for Clinical Trials, LLC Paramount, California, United States

Integrated Research Group, Inc Riverside, California, United States

View all 13 locations

View Trial Details

Completed

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

NCT02139644

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Teva Investigational Site 12397 Birmingham, Alabama, United States

Teva Investigational Site 12375 Glendale, Arizona, United States

Teva Investigational Site 12395 Cypress, California, United States

Teva Investigational Site 12476 Encinitas, California, United States

View all 140 locations

View Trial Details

Completed

A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma

NCT02680561

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Teva Investigational Site 13679 Huntington Beach, California, United States

Teva Investigational Site 13678 Raleigh, North Carolina, United States

Teva Investigational Site 13677 San Antonio, Texas, United States

View Trial Details

Lung Diseases, Obstructive

Lung Diseases, Obstructive trial results

Related conditions